Purchases and Sales Made in Q2 2023 in Cara Therapeutics, Inc. (CARA)
This table provides information about the institutional ownership of Cara Therapeutics, Inc. (CARA) during Q2 2023. The information is specifically focused on institutions that hold shares of Cara Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-96.1K- 39.34% |
$272K - $475K
|
148K
$723K
|
|
|
Aug 11, 2023
Q2 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-167K- 87.43% |
$472K - $823K
|
24K
$117K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-214K- 44.41% |
$606K - $1.06M
|
268K
$1.31M
|
|
|
Aug 07, 2023
Q2 2023
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-263K- 93.63% |
$744K - $1.3M
|
17.9K
$87.4K
|
|
|
Aug 11, 2023
Q2 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-299K- 42.22% |
$847K - $1.48M
|
410K
$2M
|
|
|
Aug 14, 2023
Q2 2023
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-329K- 16.48% |
$930K - $1.62M
|
1.67M
$8.13M
|
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-529K- 16.93% |
$1.5M - $2.61M
|
2.59M
$12.7M
|
|
|
Aug 09, 2023
Q2 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-543K- 57.39% |
$1.54M - $2.68M
|
403K
$1.97M
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-983K- 51.68% |
$2.78M - $4.86M
|
919K
$4.49M
|
|
|
Aug 14, 2023
Q2 2023
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-1.27M- 57.59% |
$3.59M - $6.27M
|
935K
$4.56M
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-3.9M- 51.31% |
$11M - $19.3M
|
3.7M
$18.1M
|